Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 564

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 2
Chunk 564
---
#
     
    Company Stockholder Support Agreement, dated as of August 30, 2024, by and among Scilex Holding Company, Semnur Pharmaceuticals, Inc. and Denali Capital Acquisition Corp(9)

35

    10.11^
     
    Sponsor Support Agreement, dated as of August 30, 2024, by and among Denali Capital Acquisition Corp., Semnur Pharmaceuticals, Inc. and each of the Persons set forth on Schedule I attached thereto(9)
  
    10.12
     
    Convertible Promissory Note, as amended, dated April 11, 2023, issued by Denali Capital Acquisition Corp. to Denali Capital Global Investments LLC(4)
  
    10.13
     
    Convertible Promissory Note, dated July 11, 2023, issued by Denali Capital Acquisition Corp. to FutureTech Capital LLC(5)
  
    10.14
     
    Convertible Promissory Note, dated October 11, 2023, issued by Denali Capital Acquisition Corp. to FutureTech Capital LLC(3)
  
    10.15
     
    Convertible Promissory Note, dated July 10, 2024, issued by Denali Capital Acquisition Corp. to Denali Capital Global Investments LLC(8)
  
    10.16
     
    Convertible Promissory Note, dated August 9, 2024, issued by Denali Capital Acquisition Corp. to Scilex Holding Company(10)
  
    10.17
     
    Deferred Discount Agreement, dated as of November 20, 2023, by and among Denali Capital Acquisition Corp., Denali SPAC Holdco, Inc., US Tiger Securities, Inc., EF Hutton, division of Benchmark Investments, LLC and Craig-Hallum Capital Group LLC(6)
  
    10.18
     
    Termination Agreement, dated as of June 26, 2024, by and among Denali Capital Acquisition Corp., Longevity Biomedical, Inc. and Bradford A. Zakes, as seller representative(11)
  
    16.1
     
    Letter Regarding Change in Accountants (12)
  
    19.1*
     
    Insider Trading Policy
  
    21.1*
     
    List of Subsidiaries
  
    31.1*
     
    Certification of Principal Executive Officer Pursuant